AR122365A1 - Composición veterinaria de anti-prolactina para rumiantes utilizada mediante administración intramamaria - Google Patents

Composición veterinaria de anti-prolactina para rumiantes utilizada mediante administración intramamaria

Info

Publication number
AR122365A1
AR122365A1 ARP210100104A ARP210100104A AR122365A1 AR 122365 A1 AR122365 A1 AR 122365A1 AR P210100104 A ARP210100104 A AR P210100104A AR P210100104 A ARP210100104 A AR P210100104A AR 122365 A1 AR122365 A1 AR 122365A1
Authority
AR
Argentina
Prior art keywords
veterinary composition
intramamary
prolactin
administration
composition
Prior art date
Application number
ARP210100104A
Other languages
English (en)
Inventor
Thierry Bertaim
Audrey Deflandre
Original Assignee
Ceva Sante Animale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Sante Animale filed Critical Ceva Sante Animale
Publication of AR122365A1 publication Critical patent/AR122365A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Fodder In General (AREA)

Abstract

Una composición veterinaria y un método para reducir la producción de leche de rumiantes lecheros, de una forma más eficaz y segura, mediante la administración de dicha composición por vía intramamaria, especialmente tras el cese del ordeño al inicio del período seco. Reivindicación 1: Una composición veterinaria que comprende cabergolina para su uso para reducir la producción de leche de un rumiante lechero, caracterizada porque dicha composición se administra a dicho rumiante lechero por vía intramamaria.
ARP210100104A 2020-01-27 2021-01-15 Composición veterinaria de anti-prolactina para rumiantes utilizada mediante administración intramamaria AR122365A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20305066 2020-01-27

Publications (1)

Publication Number Publication Date
AR122365A1 true AR122365A1 (es) 2022-09-07

Family

ID=69528716

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210100104A AR122365A1 (es) 2020-01-27 2021-01-15 Composición veterinaria de anti-prolactina para rumiantes utilizada mediante administración intramamaria

Country Status (16)

Country Link
US (1) US20230063100A1 (es)
EP (1) EP4096428B1 (es)
JP (1) JP2023511147A (es)
KR (1) KR20220132561A (es)
CN (1) CN115003164A (es)
AR (1) AR122365A1 (es)
AU (1) AU2021213891A1 (es)
BR (1) BR112022014708A2 (es)
CA (1) CA3165962A1 (es)
ES (1) ES2969031T3 (es)
HU (1) HUE064769T2 (es)
IL (1) IL294903A (es)
MX (1) MX2022009177A (es)
UY (1) UY39022A (es)
WO (1) WO2021151897A1 (es)
ZA (1) ZA202207808B (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526892A (en) 1981-03-03 1985-07-02 Farmitalia Carlo Erba, S.P.A. Dimethylaminoalkyl-3-(ergoline-8'βcarbonyl)-ureas
FR2936710B1 (fr) * 2008-10-07 2011-01-07 Ceva Sante Animale Composition veterinaire antiprolactinique destinee aux ruminants
FR2971423B1 (fr) * 2011-02-15 2014-01-10 Ceva Sante Animale Composition veterinaire antiprolactinique destinee aux ruminants
CN106389964B (zh) * 2016-11-21 2019-05-14 四川农业大学 一种奶牛回乳药物组合
AU2019272711A1 (en) * 2018-05-23 2020-11-19 Boehringer Ingelheim Vetmedica Gmbh Use of an oral bolus in the drying-off of dairy cattle

Also Published As

Publication number Publication date
MX2022009177A (es) 2022-08-17
CN115003164A (zh) 2022-09-02
UY39022A (es) 2021-07-30
US20230063100A1 (en) 2023-03-02
HUE064769T2 (hu) 2024-04-28
EP4096428C0 (en) 2023-10-11
BR112022014708A2 (pt) 2022-10-11
ES2969031T3 (es) 2024-05-16
WO2021151897A1 (en) 2021-08-05
KR20220132561A (ko) 2022-09-30
AU2021213891A1 (en) 2022-08-18
CA3165962A1 (en) 2021-08-05
EP4096428B1 (en) 2023-10-11
JP2023511147A (ja) 2023-03-16
IL294903A (en) 2022-09-01
ZA202207808B (en) 2023-03-29
EP4096428A1 (en) 2022-12-07

Similar Documents

Publication Publication Date Title
MX2021006575A (es) Composiciones y metodos para el tratamiento de trastornos del higado.
FI3197429T3 (fi) Yhdistelmähoito sglt2:n estäjillä ja dopamiiniagonisteilla aineenvaihduntahäiriöiden ehkäisemiseksi hevoseläimissä
PE20191149A1 (es) Uso farmaceutico de una composicion que contiene pirfenidona de liberacion prolongada (pfd-lp) para la reversion y tratamiento de la esteatohepatitis humana (nafld/nash)
BR112022002392A2 (pt) Formas em estado sólido de (s)-2-(((s)-6,8-difluoro-1,2,3,4-tetra-hidronaftalen-2-il)amino)-n-(1-(2-metil-1)-(neopentilamino)propan-2-il)-1h-imidazol-4-il)pentanamida e seus usos
AR037116A1 (es) Forma de dosificacion, dispositivo y metodos de tratamiento
AR097149A1 (es) Método para suministrar una composición alimenticia a rumiantes
AR122365A1 (es) Composición veterinaria de anti-prolactina para rumiantes utilizada mediante administración intramamaria
CA2470168C (en) Drink preparation comprising ketoprofen and its use in the simultaneous treatment of conditions causing fever, inflammation and pain in a herd of animals
CL2020002843A1 (es) Uso de un bolo oral en el secado de ganado lechero
RU2016119285A (ru) Кормовая добавка и способ ее применения в молочном животноводстве
CR20180305A (es) Método de alimentación de animales con productos de glucomanoproteína
BR112017007308A2 (pt) composição, método para produzir a composição, usos de uma composição e método para aumentar a produção de gordura de leite em um ruminante lactante
FR2971423B1 (fr) Composition veterinaire antiprolactinique destinee aux ruminants
AR114427A1 (es) Una composición de alimento para rumiantes que comprende polipéptidos que tienen actividad de muramidasa y métodos para mejorar la digestibilidad en rumiantes
BR102013016084A2 (pt) Composição para o tratamento de hipocalcemia em animais ruminantes
Sanyal Plasma levels of fenbendazole metabolites in buffalo and cattle after long‐term intraruminal administration
AR122366A1 (es) Composición veterinaria para rumiantes lecheros para el tratamiento de la fiebre de la leche
Bakr et al. Effect of Exogenous Progesterone in Treatment of Ovarian Inactivity in the Egyptian Dairy Parturient Buffalo-Cows.
RU2016116810A (ru) Ветеринарный способ индукции рвоты
Romagnoli An update on pseudopregnancy.
Nawaz Hypothermia: case report
Patel et al. Economics of early prophylactic treatment regimen at calving on reproductive performance in surati buffaloes
AR126894A1 (es) Composición farmacéutica de agonista de fxr y su método de preparación
Pavlović et al. Primena hormona u indukciji i sinhronizaciji estrusa i ovulacije kod krava
Velladurai et al. Ovsynch protocol for improving oestrus and conception rate in Retained Fetal Membrane (RFM) affected cows